Home » Topics » BioWorld Science

BioWorld Science
RSS

Boehringer Ingelheim and Yuhan collaborate on GLP1R/FGF21R agonist for NASH

July 2, 2019

Boston Biomedical to discontinue CanStem111P study of napabucasin in pancreatic cancer

July 2, 2019

European Commission approves Libtayo for advanced cutaneous squamous cell carcinoma

July 2, 2019

Shanghai Meiyue Biotech presents new thrombin inhibitors

July 2, 2019

Esteve Pharmaceuticals patent describes analgesic agents

July 2, 2019

GlaxoSmithKline synthesizes new IDO1 inhibitors

July 2, 2019

Parkinson's disease starts in gut, moves to brain: study

July 2, 2019

Boehringer Ingelheim patents GluN2B negative allosteric modulators

July 2, 2019

SciFluor Life Sciences divulges KCNQ2/3 activators

July 2, 2019

Results from phase II study presented for sintilimab in patients with R/R ENKTL

July 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...